Enanta Pharmaceuticals (ENTA) Current Taxes (2014 - 2018)
Enanta Pharmaceuticals posted quarterly Current Taxes of $5.9 million for Q4 2018, down 42.89% year-on-year from $10.3 million in Q4 2017, and up 322.05% on a QoQ basis from $1.4 million in Q3 2018.
Enanta Pharmaceuticals (ENTA) has 5 years of Current Taxes data on file, last reported at $5.9 million in Q4 2018.
- For the quarter ending Q4 2018, Current Taxes fell 42.89% year-over-year to $5.9 million; the trailing twelve-month figure through Dec 2018 stood at $5.9 million (down 42.89% YoY), and the FY2018 full-year result was $1.4 million, down 85.07% from the prior year.
- Current Taxes for Q4 2018 stood at $5.9 million, up from $1.4 million in the prior quarter.
- Across five years, Current Taxes topped out at $16.9 million in Q4 2014 and bottomed at $1.2 million in Q3 2015.
- The 5-year median for Current Taxes is $5.6 million (2018), against an average of $6.8 million.
- The widest annual swing landed in 2016, when Current Taxes soared 31.99%; it then slumped 85.07% in 2018.
- A 5-year view of Current Taxes shows it stood at $16.9 million in 2014, then sank by 70.76% to $4.9 million in 2015, then sank by 40.45% to $2.9 million in 2016, then jumped by 248.64% to $10.3 million in 2017, then tumbled by 42.89% to $5.9 million in 2018.
- The last three Current Taxes figures came in at $5.9 million (Q4 2018), $1.4 million (Q3 2018), and $5.4 million (Q1 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 10,460.56 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 19.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 5.86 Mn |
| Sep 30, 2018 | 1.39 Mn |
| Mar 31, 2018 | 5.38 Mn |
| Dec 31, 2017 | 10.26 Mn |
| Sep 30, 2017 | 9.30 Mn |
| Jun 30, 2016 | 2.94 Mn |
| Mar 31, 2016 | 6.78 Mn |
| Dec 31, 2015 | 4.94 Mn |
| Sep 30, 2015 | 1.20 Mn |
| Jun 30, 2015 | 2.23 Mn |
| Mar 31, 2015 | 14.54 Mn |
| Dec 31, 2014 | 16.90 Mn |